Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
329
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
-2M
-
Total reported value, excl. options
-
$6.61B
-
Value change
-
-$258M
-
Put/Call ratio
-
0.98
-
Number of buys
-
129
-
Number of sells
-
-181
-
Price
-
$129.49
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2014
382 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2014.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 329 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
.
Largest 10 shareholders include FMR LLC (3.96M shares), VANGUARD GROUP INC (3.01M shares), SCOPIA CAPITAL MANAGEMENT LP (2.96M shares), LSV ASSET MANAGEMENT (2.16M shares), BlackRock Fund Advisors (1.97M shares), ACADIAN ASSET MANAGEMENT LLC (1.7M shares), BlackRock Advisors LLC (1.68M shares), AJO, LP (1.56M shares), DEUTSCHE BANK AG\ (1.48M shares), and BlackRock Institutional Trust Company, N.A. (1.46M shares).
This table shows the top 329 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.